Author： Harwood Jr H.J. Hamanaka E.S.
Publisher： Informa Healthcare
ISSN： 1472-8214
Source： Expert Opinion on Emerging Drugs, Vol.3, Iss.1, 1998-06, pp. : 147-172
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Dyslipidaemia treatment guidelines `are outdated'
Inpharma, Vol. 1, Iss. 1246, 2000-01 ,pp. :
Access to resources
Recommend
Management of diabetic dyslipidaemia
Inpharma, Vol. 1, Iss. 1482, 2005-01 ,pp. :
Canadian guidelines for the management of dyslipidaemia
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 265, 2000-01 ,pp. :
LY 518674 for dyslipidaemia, hypercholesterolaemia
Inpharma, Vol. 1, Iss. 1581, 2007-01 ,pp. :
Novel agents for managing dyslipidaemia
By Jenkins Alicia J Best James D
Expert Opinion on Investigational Drugs, Vol. 10, Iss. 11, 2001-11 ,pp. :